The last few years have witnessed a great surge of interest in the role of DNA repair mechanisms in human health and disease. We owe this, at least in part, to a recessive autosomal condition xeroderma pigmentosum (XP), which has offered a dramatic demonstration of the severe clinical consequences of DNA repair defects (Robbins et al. 1974 , Giannelli 1976 .
We have always had reason to consider our genetic material as a stable substance which is handed down from generation to generation relatively unchanged. In fact, estimates of mutation rates for inheritable pathologic traits give values of roughly 10-' mutations per locus, per gamete, per generation and, similarly, mutants resistant to 8-azaguanine or 6-thioguanine occur with a frequency of approximately 2-5 x 10 6 per locus per cell generation in fibroblasts cultured in vitro (Vogel & Rathenberg 1975 , Albertini & DeMars 1973 , Cox & Masson 1976 .
Recently, however, it has become apparent that the relative stability of our genetic material is not so much a property of DNA itself, but it is rather the net result of the balance between the contrasting processes of DNA damage and accurate repair. It can be calculated that in a day the DNA of a mammalian cell may undergo tens, if not hundreds of thousands of chemical changes which could cause cell death or mutations if they were not repaired or were incorrectly mended (Verly 1975 , Trosko et al. 1970 . The industrial development of the last hundred years, and the great expansion of the chemical industry has led to the introduction of a great variety of damaging substances in our environment. However, with regard to the skin, the most important DNA damaging agent is sunlight. Epidemiological work now suggests that the incidence of, at least, squamous and basal cell carcinoma is largely dependent on geographical, climatic, anatomical and genetic factors which determine the amount of light penetrating the skin (Segi 1963 , Keeler 1963 , Urbach 1969 , Urbach et al. 1974 . Sunlight seems possibly to contribute also to the etiology of melanoma (Lee & Merrill 1971 , Urbach et al. 1974 .
Experimental work has shown that, in the absence of sensitizing substances, light of wavelength greater than 320 nm is essentially noncarcinogenic, even if it does contribute to the carcinogenic action ofshorter wavelengths as suggested by Urbach et al. (1974) (see also Blum 1959 , Epstein 1966 , Freeman 1975 . Since sunlight of wavelength shorter than 290 nm is filtered out by the outer layers of the atmosphere, it seems reasonable to consider wavelengths of 290-320 nm as the most likely to cause actinic cancer in man. The action spectrum for such human cancer is, however, not yet precisely known.
Patients with XP are specifically sensitive to the short wavelengths mentioned above, although, in some, sensitivity may extend slightly above 320 nm up to 340 nm, as shown by tests with artificial monochromatic light (Ramsay & Giannelli 1975 ). The exposed skin of these individuals, in the first few years of life, undergoes the changes (except elastosis) which are characteristic of solar degeneration. These are normally observed only in old people who have received very high cumulative doses of sunlight.
After a brief phase, marked only by acute sunburn episodes and by photophobia, XP patients begin to show permanent skin abnormalities such as dyschromia, atrophy, and telangiectasias on the exposed parts of the body. These are followed by neoplastic growths which start from multiple foci and continue to occur, often causing the patient's death in the second or third decade of life (Fig 1) . A biologically and clinically important feature of XP is its frequent association with neurological complications which appear to be due to neurone loss unaccompanied by inclusion bodies or glial reactions. These complications may vary in type and severity and include mental retardation, motoneural disorders, depression or absence of tendon reflexes and, sometimes, cranial nerve involvement mainly in the form of sensorineural deafness.
Nowadays it seems possible to retard the dermatological course of the disease by diagnosing the condition very early and preventing exposure to sunlight (Fig 2) . How then, does UV light damage our DNA, and why are XP patients so sensitive to its action?
The absorption of photons by the DNA leads to a variety of chemical changes of which the most frequent, and perhaps biologically the most important, are pyrimidine dimers. These arise by the transformation of the energy absorbed by the DNA into chemical bonds between adjacent pyrimidines of the same DNA strand (Fig 3) . The formation ofa pyrimidine dimer causes breakage of the hydrogen bonds between the two strands of the DNA in the region of the dimer and its immediate neighbourhood. A fairly large distortion of the DNA molecule is thus produced. Such distortion hinders DNA replication or its translation into RNA and must be removed. There are two systems for the removal of pyrimidine dimers: enzymatic photoreactivation and excision repair. The first is strictly specific for pyrimidine dimers and relies on the function of a single enzyme. This binds to the dimer, even in the dark. Then, under the influence of light, it splits the chemical bonds between the two pyrimidines and re-establishes normality.
Past work has shown that enzymatic photoreactivation exists in most forms of life except mammals (Cleaver 1966 , Cook 1970 unpublished) . Consequently they also show reduced excision of pyrimidine dimers and DNA repair synthesis. The latter anomaly is very easy to detect and has been used for diagnostic purposes as shown in Fig 5. Similarly, the analysis of DNA repair synthesis in amniotic cell cultures of fetuses at risk has permitted the prenatal diagnosis of XP - (Ramsay et al. 1974 ).
Since in XP the excision repair defect appears to involve always the first step, the disease would seem to be biochemically homogeneous. However, genetic studies have revealed a high degree of genetic heterogeneity. These studies, based on the technique of somatic cell fusion (outlined in Fig 6) have shown that, upon fusion, the fibroblasts of different patients may either complement each other and hence show correction of the defective DNA repair synthesis, or fail to complement and show no improvement. In the first case, the patients must carry different genetic defects and they are said to belong to different complementation groups. In the second case, they are assigned to the same complementation group and presumably carry the same mutation.
Cell fusion studies of this type are summarized in Table 1 . These show that 32 unrelated XP patients fall into five complementation groups (A to E) of which groups A, C, and D, are the most numerous. The worst affected patients tend to belong to group A since they often show neurological complications (8/11). These have so far spared all patients in group C and 4 out of 6 in group D.
The genetic heterogeneity of XP emphasizes the important point that many genes are involved in the maintenance of DNA. First, as many as five genes may control only one of the many steps of the excision repair of pyrimidine dimers. Secondly, different excision repair systems must exist to cope with different families of DNA lesions. Finally, repair systems other than excision are available to human cells. One can therefore expect that a variety of conditions due to defects of DNA repair are yet to be found, and that mutations in genes responsible for the maintenance of DNA may make an important contribution to human morbidity.
In contrast with the majority of XP patients, a group comprising roughly 10-20 % of such patients shows normal excision but defective post-replication repair. This group is clinically indistinguishable from the rest but is called 'XP-variant', because of its distinct biochemical defect. In contrast with excision, post-replication repair does not act by removing pyrimidine dimers but enables the cells to overcome the difficulties that the dimers impose on DNA replication. It is believed that these temporarily block DNA synthesis so that in UV-irradiated cells the newly replicated DNA strands have interruptions opposite pyrimidine dimers. The block is then overcome by a repair mechanism in a manner which is still the object of much speculation (Lehmann et al. 1975 , Meneghini & Hanawalt 1976 , Higgins et al. 1976 ). XP-variant cells overcome the block, caused by UV lesions, at a slower rate than controls and this difference may be accentuated by caffeine (Lehmann et al. 1975) . Naturally, if interruptions are repaired slowly in XP variants, the molecular weight of their newly replicated DNA strands will tend to reach high values later than normal. Differences in the ef-ficiency of post-replication repair are, therefore, reflected in the kinetics of the increase in molecular weight of DNA synthesized during the first few hours after UV irradiation. DNA molecular weight can be measured by sedimentation in alkaline sucrose gradients where longer, and hence heavier, DNA strands sediment faster than shorter and lighter ones. At short intervals after UV irradiation, this method shows that XP-variant cells synthesize DNA of lower molecular weight than controls (Fig 7) .
The phenotype of XP and XP variants allows the conclusion that distinct metabolic defects impairing either the removal of pyrimidine dimers or the bypass of these lesions during DNA replication result in susceptibility to actinic cancer. Since epidemiological evidence indicates that sunlight plays an important role in the etiology of skin cancer, the conclusion that a direct causal relationship exists between DNA damage and skin cancer seems inescapable. Hart & Setlow (1975) have provided some direct experimental evidence indicating that pyrimidine dimers may lead to malignant transformation. They have used parthenogenetic clones of Poecilia formosa, a fish with efficient enzymatic photoreactivation, and have found that fishes injected with a suspension of 105 UV-irradiated (20 J/m2) cells prepared from members of their clone, developed thyroid carcinomas in 100 % of cases. If, however, this cell suspension was treated, before injection, with photoreactivating light, a ten-fold reduction in the incidence of thyroid carcinomas was observed. Since the photoreactivation treatment should have specifically repaired at least part of the pyrimidine dimers produced by UV light, its effect on the incidence of tumours can be taken as evidence that pyrimidine dimers are important in malignant transformation. Photoreactivation treatment alone or prior to UV irradiation had no effect on tumour incidence since the cell's DNA had no dimers to be acted upon.
There is, therefore, little doubt that the DNA damage caused by sunlight may result in cancer of the skin. How does such DNA damage lead to malignant transformation? Naturally, those who strongly support the mutational theory of cancer will say that DNA damage acts by causing mutations. Those in favour of the viral etiology of cancer will propose that DNA damage favours virus-induced cell transformation. Finally, those who have very strong feelings about the role of immunological surveillance in the prevention of cancer, or are in general concerned with the compiex relationships between a cancer cell and its host, will submit that the cellular sensitivity to UV light, caused by defects of DNA repair, may favour tumour growth in a number of different indirect ways. These three hypotheses are not mutually exclusive and we should consider how much evidence in favour of each has been provided specifically in the case of XP.
There is a wealth of information indicating that XP cells are more sensitive than controls to the chromosome-damaging action of UV light or of UV-mimetic chemicals (Parrington et al. 1971 , Stich et al. 1973 , Sasaki 1973 , Marshall & Scott 1976 ; and good evidence that XP and XP-variant cells are very sensitive to the mutagenic effect of UV light has recently become available (Maher & McCormick 1976) . These data, therefore, provide support for the mutagenic theory of cancer, and it could be argued that the process of actinic carcinogenesis, which in normal individuals takes place slowly and manifests itself only at advanced age, is telescoped in XP into the first few years of life because of the faster rate at which XP cells accumulate UV-induced mutations.
Convincing evidence of susceptibility to transformation by oncogenic viruses has not been obtained in XP cells. In fact, Key & Todaro (1974) found that the oncogenic virus SV40 did not transform XP cells more easily than controls either with or without the help of UV light. This fact, per se, cannot be considered to dispose of the viral theory; the SV40 approach, important though it might be, is not absolute and it cannot yet be excluded that viruses play a role in the etiology of cancer in XP. Dulbecco (1976) has recently considered evidence suggesting that cellular mutations may be needed for the full expression of cell transformation by papova viruses. If so, it would seem plausible to think that the susceptibility to light-induced mutations characteristic of XP may favour viral oncogenesis in the presence of appropriate viral elements.
Finally, with regard to the indirect effects of DNA repair defects on the development of cancer, it must be said that because of the complex relationship existing between the tumour cell and its host, the idea that events not directly related to malignant transformation play a part in tumour development seems rather attractive. However, it is easier to suggest ways in which such indirect effects may take place than to find experimental proof. It is possible, for instance, to suggest that the UV sensitivity of XP cells may favour tumour growth by altering the normal physiology of the skin, thus, for example, accelerating cellular turnover, and favouring the growth of cells with poor responses to the regulatory action of chalones (see Marks 1976) . Similarly, it is possible to suggest that the repair defect in XP may interfere with immunological surveillance by inhibiting the multiplication of immune-competent cells or by favouring the release of tumour-associated antigens which may block the immunological defences (Alexander et al. 1975) . Dupuy & Lafforet (1974) have in fact claimed that XP patients are immunologically incompetent to a degree, but their claim has not yet been verified.
In conclusion, work so far has provided mainly evidence for the influence of mutations on the origin of XP-related cancer, and thus more generally for the mutagenic theory of cancer, but experimentation to test the other hypotheses in XP is still needed.
More generally, XP has taught us other important lessons. It has vividly shown that the stability of DNA is dependent on the function of repair systems whose failure may result in susceptibility to cancer. Furthermore its genetic heterogeneity has stressed the point that in man many genes may control DNA repair and be of importance in carcinogenesis. This is being brought out more and more by the discovery of other conditions with defects of DNA metabolism and high incidence of cancer.
Prominent among these is Bloom's syndrome, a light-sensitive condition of marked pre-and postnatal growth retardation, high incidence of cancer, and chromosomal instability, in which an impairment of DNA synthesis has been detected (Giannelli, Benson et al. 1977) . Besides Bloom's syndrome, ataxia-telangiectasia and Fanconi's anemia are two conditions in which developmental defects, chromosomal instability, high risk of cancer, defects in DNA repair and a degree of immune incompetence seem to go hand in hand (Polani 1976 , Paterson et al. 1976 , Fujiwara & Tatsumi 1975 , Remsen & Cerutti 1976 . Others no doubt, are still to be found.
XP, Bloom's syndrome, ataxia-telangiectasia, and Fanconi's anxmia are all rare recessive disorders and one may perhaps consider them as accidents of nature which, though advancing our understanding of human pathology, are rather irrelevant to human morbidity. This may not be quite true, however, since the prevalence ofcarriers for the above conditions is many times higher than that of the diseases themselves. For example, one may calculate that, although the incidence of Fanconi's anxmia may be of the order of 2/106, heterozygotes for this condition should have a frequency of 1/350. Therefore, carriers of mutation at gene loci which control DNA replication and repair may represent a not inconsiderable fraction of the population. At least some of these heterozygotes are known to be at a high risk of cancer (Swift 1976) and it seems possible that carriers of mutations affecting DNA replication and repair may represent an important part of the population genetically prone to cancer.
In conclusion: XP has not only helped in the understanding of skin carcinogenesis, but has also stimulated the search for defects of DNA metabolism, which may play an important general role in oncogenesis.
Strategy in the Management of Melanoma
At the present time the prognosis for disseminated melanoma is to all intents and purposes hopeless. The outlook in the presence of regional lymphatic spread in the form of skin nodules or involved lymph nodes is poor but not hopeless. The chances of cure are greatest in clinical stage I, i.e. primary tumour only.
Clinical Stage I Malignant melanomas exhibit a wide range of biological behaviour, from the most aggressive to the readily curable. The behaviour pattern in the individual case can be predicted within limits according to certain clinical and pathological criteria. To some extent this pattern determines the plan of management and therefore calls for brief discussion. The clinical classification and histological depth staging advocated by Clark et al. (1975) are widely used. They recognize three main clinical varieties: lentigo-maligna melanoma; superficial spreading melanoma; and nodular melanoma.
Lentigo-maligna melanoma: This is seen usually on the face of the elderly in skin showing the changes of chronic solar damage. It is preceded, often for very many years, by a herald lesion in the form of a slowly extending flat, black patch sometimes showing areas of regression (precancerous melanosis of Dubreuilh). The appearance of a nodule or nodules in the patch indicates that malignant change has supervened. This is the least aggressive type of melanoma with a low incidence of lymph node spread. Excision of precancerous melanosis forestalls the development of the malignant phase. Superficial spreading melanoma: This is found in the female more commonly on the lower limb and in the male more often on the trunk. It occurs in middle life and develops over a number of years as a flat, pigmented plaque which spreads peripherally in indolent fashion and finally changes its behaviour with the development of an invasive element, appearing clinically as a thickening or nodule which may ulcerate. It is the commonest type of melanoma. Its tendency to involve lymph nodes and spread more widely lies somewhere between that of the lentigo-maligna melanoma and nodular melanoma. The chances of cure fall with the development of the invasive phase. Education of the profession and the public to take action at the earliest sign of change in a pigmented lesion should reduce mortality in this group.
Nodular melanoma: This lesion is nodular and invasive from outset without the preliminary phase of spreading pigmentation of the first two types. It carries the worst prognosis.
Histological Guides to Prognosis These have been well summarized by McGovern (1976) . They concern principally depth of penetration, the thickness of the lesion and its histological grading. Increasing depth of histological invasion is accompanied by a progressive rise in
